Preci aims to bridge the gap between animal testing and the outcome of the clinical trial.
At Preci we collect human-derived cancer tissues to increase the availability and the diversity of the cell models, suitable for testing. We are ready to provide high-quality services for both the early stages of drug discovery and preclinical development.
We trust that most human-relevant cell models will bring efficiency to modern Drug Discovery.
Phenotypic complexity of human tissue hinders most attempts to model it. At preci we use only human-derived model with low or no phenotypic alteration. Our models contain REAL human cells and REAL human-derived extracellular matrix.